Actually there have been several financial allocations. In fact, there's a provision for a roughly $25 million investment from CIHR to be matched by different countries. We're talking about several MOUs. There's one with the U.K. and Germany; there's one with France; there's one with the U.S. The most recent one is with China. The focus of these international collaborative studies is the early diagnosis and early treatment of the disease. We believe if we haven't been successful in our treatment of Alzheimer's, to a large extent it is because we've started treating too late and at a time when the degeneration was probably too advanced. Our goal is truly to devise means of diagnosing the disorders much earlier so that we can treat them more effectively.
On November 21st, 2011. See this statement in context.